SNP ID | Genotype | Breast cancer | Control | P-value Adj. a | OR (95%CI) Adj. |
---|---|---|---|---|---|
rs3834129 | DD | 58 (12.9%) | 95 (17.2%) | Reference | Â |
ID | 185 (41.1%) | 261 (47.2%) | 0.158 | 1.49 (0.86–2.59) | |
II | 207 (46.0%) | 197 (35.6%) | 0.008 | 2.14 (1.22–3.75) | |
D | 301 (33.4%) | 451 (40.8%) | Reference | Â | |
I | 599 (66.6%) | 655 (59.2%) | 0.011 | 1.43 (1.15–1.78) | |
rs2037815 | AA | 80 (17.8%) | 130 (23.5%) | Reference | Â |
GA | 261 (58.0%) | 301 (54.4%) | 0.514 | 1.15 (0.75–1.75) | |
GG | 109 (24.2%) | 122 (22.1%) | 0.502 | 0.84 (0.51–1.39) | |
A | 421 (46.8%) | 561 (50.7%) | Reference | Â | |
G | 479 (53.2%) | 545 (49.3%) | 0.684 | 1.04 (0.85–1.29) | |
rs7608692 | GG | 161 (35.8%) | 249 (45.0%) | Reference | Â |
GA | 211 (46.9%) | 215 (38.9%) | 0.006 | 1.52 (1.12–2.04) | |
AA | 78 (17.3%) | 89 (16.1%) | 0.136 | 1.35 (0.91-2.00) | |
G | 533 (59.2%) | 713 (64.5%) | Reference | Â | |
A | 367 (40.8%) | 393 (35.5%) | 0.179 | 1.16 (0.93–1.44) | |
rs12990906 | CC | 69 (15.3%) | 111 (20.1%) | Reference | Â |
TC | 196 (43.6%) | 248 (44.8%) | 0.172 | 1.41 (0.86–2.30) | |
TT | 185 (41.1%) | 194 (35.1%) | 0.712 | 1.09 (0.69–1.73) | |
C | 334 (37.1%) | 470 (42.5%) | Reference | Â | |
T | 566 (62.9%) | 636 (57.5%) | 0.026 | 1.27 (1.03–1.58) | |
rs3769821 | TT | 273 (60.7%) | 361 (65.3%) | Reference | Â |
TC | 147 (32.7%) | 143 (25.9%) | 0.389 | 1.18 (0.81–1.72) | |
CC | 30 (6.7%) | 49 (8.9%) | 0.92 | 1.03 (0.54–1.96) | |
T | 693 (77.0%) | 865 (78.2%) | Reference | Â | |
C | 207 (23.0%) | 241 (21.8%) | 0.533 | 1.08 (0.84-1-39) | |
rs6435074 | CC | 227 (50.4%) | 294 (53.2%) | Reference | Â |
CA | 181 (40.2%) | 218 (39.4%) | 0.841 | 1.06 (0.57–1.98) | |
AA | 42 (9.3%) | 41 (7.4%) | 0.924 | 1.03 (0.55–1.93) | |
C | 635 (70.6%) | 806 (72.9%) | Reference | Â | |
A | 265 (29.4%) | 300 (27.1%) | 0.856 | 1.02 (0.81–1.29) | |
rs3754934 | CC | 385 (85.6%) | 464 (84.1%) | Reference | Â |
CA | 51 (11.3%) | 75 (13.6%) | 0.002 | 0.41 (0.23–0.73) | |
AA | 14 (3.1%) | 13 (2.4%) | 0.856 | 0.89 (0.26–3.07) | |
C | 821 (91.2%) | 1005 (91.9%) | Reference | Â | |
A | 79 (8.8%) | 101 (8.1%) | 0.051 | 1.50 (0.99–2.27) | |
rs3817578 | TT | 8 (1.8%) | 16 (2.9%) | Reference | Â |
CT | 119 (26.4%) | 142 (25.7%) | 0.555 | 0.89 (0.60–1.32) | |
CC | 323 (71.8%) | 395 (71.4%) | 0.88 | 0.91 (0.29–2.91) | |
T | 135 (15.0%) | 174 (15.7%) | Reference | Â | |
C | 765 (85.0%) | 932 (84.3%) | 0.993 | 1.00 (0.74–1.35) | |
rs10931936 | CC | 245 (54.4%) | 396 (71.6%) | Reference | Â |
CT | 168 (37.3%) | 122 (21.1%) | < 0.001 | 2.31 (1.57–3.39) | |
TT | 37 (8.2%) | 35 (6.3%) | 0.372 | 1.34 (0.70–2.65) | |
C | 658 (73.1%) | 914 (82.6%) | Reference | Â | |
T | 242 (26.9%) | 192 (17.4%) | < 0.001 | 1.73 (1.34–2.23) | |
rs1045485 | CC | 30 (6.7%) | 56 (10.1%) | Reference | Â |
GC | 127 (28.2%) | 142 (25.7%) | 0.744 | 1.07 (0.72–1.58) | |
GG | 293 (65.1%) | 355 (64.2%) | 0.28 | 0.69 (0.35–1.35) | |
C | 187 (20.8%) | 254 (23.0%) | Reference | Â | |
G | 713 (79.2%) | 852 (77.0%) | 0.296 | 1.15 (0.88–1.45) | |
rs1045487 | GG | 321 (71.3%) | 403 (72.9%) | Reference | Â |
GA | 111 (24.7%) | 135 (24.4%) | 0.912 | 1.02 (0.68–1.53) | |
AA | 18 (4.0%) | 15 (2.7%) | 0.113 | 2.30 (0.82–6.44) | |
G | 753 (83.7%) | 941 (85.1%) | Reference | Â | |
A | 147 (16.3%) | 165 (14.9%) | 0.15 | 1.24 (0.92–1.67) | |
rs13113 | TT | 170 (37.8%) | 228 (41.2%) | Reference | Â |
TA | 204 (45.3%) | 250 (45.2%) | 0.804 | 1.04 (0.72–1.52) | |
AA | 76 (16.9%) | 75 (13.6%) | 0.285 | 1.33 (0.79–2.24) | |
T | 544 (60.4%) | 706 (63.8%) | Reference | Â | |
A | 356 (39.6%) | 400 (36.2%) | 0.133 | 1.18 (0.95–1.46) |